Patents by Inventor Hugh John Field

Hugh John Field has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020155131
    Abstract: Vaccine formulation comprising EHV-1 gene 71 dysfunctional mutant and uses thereof.
    Type: Application
    Filed: October 19, 2001
    Publication date: October 24, 2002
    Applicant: University Court of The University of Glasgow
    Inventors: Susanne Moira Brown, Yi Sun, Hugh John Field
  • Patent number: 5916893
    Abstract: A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: June 29, 1999
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Hugh John Field, Alana Maureen Thackray, Teresa Helen Bacon, David Sutton, Richard Anthony Vere Hodge
  • Patent number: 5840763
    Abstract: A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.
    Type: Grant
    Filed: September 1, 1995
    Date of Patent: November 24, 1998
    Assignee: SmithKline Beecham plc
    Inventors: Hugh John Field, Alana Maureen Thackray, Teresa Helen Bacon, David Sutton, Richard Anthony Vere Hodge